Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine the potential safety and effectiveness of rebamipide eye drops, an investigational eye drop being developed for the treatment of keratoconjunctivitis sicca (d...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Collaborators
NCT03953703 · Sjogren's Syndrome, Keratoconjunctivitis Sicca
NCT05918406 · Dry Eye, Keratoconjunctivitis Sicca
NCT00411827 · Keratoconjunctivitis Sicca
NCT04421300 · Dry Eye, Keratoconjunctivitis Sicca, and more
NCT03925727 · Keratoconjunctivitis Sicca, Dry Eye
Alabama Research Center, LLC
Birmingham, Alabama
Sun Valley Arthritis Center, Ltd.
Glendale, Arizona
Pivotel Research Center
Peoria, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions